目的探讨血清脂肪酶在慢性肾脏疾病患者血清中表达的变化。
Objective To study the change of lipase expression in patients with chronic kidney disease.
诊断程序一般包括CBC(全血细胞计数)，血清生化(评估胰脂肪酶和胰淀粉酶)，尿检。
Diagnostic procedures commonly include a CBC, or complete blood count, a serum chemistry that evaluates the pancreatic enzymes amylase and lipase, and a urinalysis.
淀粉酶(AMYL)提升表示胰脏炎，当血清胰脂肪酶也高的时候，或因肾疾病存在而增加。
Amylase (AMYL) elevations show pancreatitis, when the serum lipase is also high, or become increased in the presence of kidney disease.
结论脂肪酶测定是诊断急、慢性肾功能衰竭患者良好的血清酶学指标。
Conclusion the serum lipase is the effective index of the diagnosis on the acute or chronic kidney insufficiency.
结论：泰脂安对高脂模型大鼠有较好的降脂作用，其降脂作用机制可能与泰脂安升高血清中的脂蛋白脂肪酶含量有关。
CONCLUSION: Taizhi "an capsule can decrease the hyperlipidemia. Its mechanism is related to the regulation of lipid metabolism and improvement of the concentration of LPL (lipoprotein lipase)."
再灌注30分钟、1小时血清淀粉酶和脂肪酶比再灌注0分钟明显升高（P< 0.01）；
The levels of serum amylase and lipase significantly increased 30 min, 1 hour after reperfusion (P<0.01);
再灌注30分钟、1小时血清淀粉酶和脂肪酶比再灌注0分钟明显升高（P< 0.01）；
The levels of serum amylase and lipase significantly increased 30 min, 1 hour after reperfusion (P<0.01);
应用推荐